Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

IRIDEX Corp (IRIX) USD0.01

Sell:$7.67 Buy:$7.70 Change: $0.20 (2.67%)
Market closed |  Prices as at close on 16 April 2021 | Switch to live prices |
Sell:$7.67
Buy:$7.70
Change: $0.20 (2.67%)
Market closed |  Prices as at close on 16 April 2021 | Switch to live prices |
Sell:$7.67
Buy:$7.70
Change: $0.20 (2.67%)
Market closed |  Prices as at close on 16 April 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

IRIDEX Corporation is a provider of therapeutic based laser consoles, delivery devices and consumable instrumentation used to treat sight-threatening eye diseases in ophthalmology. The Company operates through ophthalmology segment. Its ophthalmology products consist of laser consoles, delivery devices and consumable instrumentation, including laser probes, and are used in the treatment of serious eye diseases, including the over three causes of irreversible blindness, such as diabetic retinopathy, glaucoma and age-related macular degeneration (AMD). In addition, the Company's ophthalmology products are often used in vitrectomy procedures (used to treat proliferative diabetic retinopathy, macular holes, retinal tears and detachments), which are generally performed in the operating room and require a consumable single use intraocular laser probe (EndoProbe) to deliver light to the back of the eye together with other instrumentation.

Contact details

Address:
1212 Terra Bella Ave
MOUNTAIN VIEW
94043-1824
United States
Telephone:
+1 (650) 9404700
Website:
www.iridex.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
IRIX
ISIN:
US4626841013
Market cap:
$115.01 million
Shares in issue:
15.52 million
Sector:
Health Care Equipment
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Robert Gunst
    Independent Chairman of the Board
  • David Bruce
    President, Chief Executive Officer, Director
  • Fuad Ahmad
    Interim Chief Financial Officer
  • Patrick Mercer
    Chief Operating Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.